Posterior cortical atrophy: clinical, neuroimaging, and neuropathological features

References

• Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol. 1988;45(7):789–793.
   PubMedGoogle Scholar
• Crutch SJ, Lehmann M, Schott JM, et al. Posterior cortical atrophy. Lancet Neurol. 2012;11(2):170–178.
   PubMed Web of Science ®Google Scholar
• Pietrini P, Furey ML, Graff-Radford N, et al. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer’s disease: clinical implications. Am J Psychiatry. 1996;153:1261–1268.
   PubMedGoogle Scholar
• Renner JA, Burns JM, Hou CE, et al. Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology. 2004;63(7):1175–1180.
   PubMed Web of Science ®Google Scholar
• Caroppo P, Belin C, Grabli D, et al. Posterior cortical atrophy as an extreme phenotype of GRN mutations. JAMA Neurol. 2015;72(2):224–228.
   PubMed Web of Science ®Google Scholar
• Goodale MA, Milner AD. Separate visual pathways for perception and action. Trends Neurosci. 1992;15(1):20–25.
   PubMed Web of Science ®Google Scholar
• Kravitz DJ, Saleem KS, Baker CI, et al. A new neural framework for visuospatial processing. Nat Rev Neurosci. 2011;12(4):217–230.
   PubMed Web of Science ®Google Scholar
• Lehmann M, Barnes J, Ridgway GR, et al. Basic visual function and cortical thickness patterns in posterior cortical atrophy. Cereb Cortex N Y N 1991. 2011;21:2122–2132
   PubMed Web of Science ®Google Scholar
• Townley RA, Botha H, Graff-Radford J, et al. Posterior cortical atrophy phenotypic heterogeneity revealed by decoding 18F-FDG-PET. Brain Commun. 2021;3(4):fcab182.
   PubMedGoogle Scholar
• Groot C, Yeo BTT, Vogel JW, et al. Latent atrophy factors related to phenotypical variants of posterior cortical atrophy. Neurology. 2020;95(12):e1672–e1685.
   PubMedGoogle Scholar
• Shir D, Graff‐Radford J, Machulda MM, et al. Posterior cortical atrophy: primary occipital variant. Eur J Neurol. 2022;29(7):2138–2143.
   PubMedGoogle Scholar
• Schott JM, Crutch SJ, Carrasquillo MM, et al. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer’s disease. Alzheimers Dement J Alzheimers Assoc. 2016;12(8):862–871.
   PubMedGoogle Scholar
• Olds JJ, Hills WL, Warner J, et al. Posterior cortical atrophy: characteristics from a clinical data registry. Front Neurol. 2020;11:358.
   PubMedGoogle Scholar
• Graff-Radford J, Yong KXX, Apostolova LG, et al. New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol. 2021;20(3):222–234.
   PubMed Web of Science ®Google Scholar
• Quental NBM, Brucki SMD, Bueno OFA. Visuospatial function in early alzheimer’s disease—the use of the Visual Object and Space Perception (VOSP) battery. PLOS ONE. 2013;8(7):e68398.
   PubMed Web of Science ®Google Scholar
• Miller ZA, Rosenberg L, Santos-Santos MA, et al. Prevalence of mathematical and visuospatial learning disabilities in patients with posterior cortical atrophy. JAMA Neurol. 2018;75(6):728–737.
   PubMedGoogle Scholar
• Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer’s disease. Brain J Neurol. 2007;130(10):2636–2645.
   Google Scholar
• Tang-Wai DF, Graff-Radford NR, Boeve BF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 2004;63(7):1168–1174.
   PubMed Web of Science ®Google Scholar
• Spina S, La Joie R, Petersen C, et al. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease. Brain. 2021;144(7):2186–2198.
   PubMedGoogle Scholar
• Baiardi S, Capellari S, Ladogana A, et al. Revisiting the heidenhain variant of creutzfeldt-jakob disease: evidence for prion type variability influencing clinical course and laboratory findings. J Alzheimers Dis. 2016;50(2):465–476.
   PubMed Web of Science ®Google Scholar
• Petersen C, Nolan AL, de Paula França Resende E, et al. Alzheimer’s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation. Acta Neuropathol (Berl). 2019;138(4):597–612.
   PubMedGoogle Scholar
• Xia C, Makaretz SJ, Caso C, et al. Association of In Vivo [18 F]AV-1451 Tau PET imaging results with cortical atrophy and symptoms in typical and atypical Alzheimer disease. JAMA Neurol. 2017;74(4):427–510.
   PubMedGoogle Scholar
• Day GS, Gordon BA, Jackson K, et al. Tau-PET binding distinguishes patients with early-stage posterior cortical atrophy from amnestic Alzheimer disease dementia. Alzheimer Dis Assoc Disord. 2017;31(2):87–93.
   PubMedGoogle Scholar
• Nolan A, De Paula Franca Resende E, Petersen C, et al. Astrocytic Tau deposition is frequent in typical and atypical Alzheimer disease presentations. J Neuropathol Exp Neurol. 2019;78(12):1112–1123.
   PubMedGoogle Scholar
• Munoz DG, Woulfe J, Kertesz A. Argyrophilic thorny astrocyte clusters in association with Alzheimer’s disease pathology in possible primary progressive aphasia. Acta Neuropathol (Berl). 2007;114(4):347–357.
   PubMed Web of Science ®Google Scholar
• Resende E de PF, Nolan AL, Petersen C, et al. Language and spatial dysfunction in Alzheimer disease with white matter thorn-shaped astrocytes. Neurology. 2020;94(13):e1353–e1364.
   PubMedGoogle Scholar
• Day BL, Ocal D, Peters A, et al. Altered visual and haptic verticality perception in posterior cortical atrophy and Alzheimer’s disease. J Physiol [Internet]. Cited 2022 Jan 13;600(2):373–391. n/a. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1113/JP282289
   PubMedGoogle Scholar
• Charles RF, Hillis AE. Posterior cortical atrophy: clinical presentation and cognitive deficits compared to alzheimer’s disease. Behav Neurol. 2005;16:15–23.
   PubMed Web of Science ®Google Scholar
• Crutch SJ, Warrington EK. The relationship between visual crowding and letter confusability: towards an understanding of dyslexia in posterior cortical atrophy. Cogn Neuropsychol. 2009;26(5):471–498.
   PubMed Web of Science ®Google Scholar
• Donovan NJ, Locascio JJ, Marshall GA, et al. Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults. Am J Psychiatry. 2018;175(6):530–537.
   PubMed Web of Science ®Google Scholar
• The Heidenhain Variant of Creutzfeldt-Jakob Disease | dementia and Cognitive Impairment | JAMA Neurology | JAMA Network [Internet]. [Cited 2022 Jul 29]. Available from: https://jamanetwork.com/journals/jamaneurology/fullarticle/774662.
   Google Scholar
• Schott JM, Crutch SJ. Posterior cortical atrophy. Contin Lifelong Learn Neurol. 2019;25(1):52.
   Google Scholar
• Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006–1014.
   PubMed Web of Science ®Google Scholar
• Tee BL, Gorno-Tempini ML. Primary progressive aphasia: a model for neurodegenerative disease. Curr Opin Neurol. 2019;32(2):255–265.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick D, Blanco-Campal A, Kyne L. A case of overlap posterior cortical atrophy and logopenic variant primary progressive aphasia. Neurologist. 2019;24(2):62–65.
   PubMedGoogle Scholar
• Lee JC, Kim SJ, Hong S, et al. Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers. Exp Mol Med. 2019;51(12):1–10.
   Web of Science ®Google Scholar
• Jack CR, Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement J Alzheimers Assoc. 2018;14(4):535–562.
   PubMed Web of Science ®Google Scholar
• Andreasen N, Hesse C, Davidsson P, et al. Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease: differences between early- and late-onset Alzheimer's disease and stability during the course of disease. Arch Neurol. 1999;56(6):673–680.
   PubMedGoogle Scholar
• McGuire LI, Peden AH, Orrú CD, et al. RT-QuIC analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2012;72(2):278–285.
   PubMed Web of Science ®Google Scholar
• Teunissen CE, Verberk IMW, Thijssen EH, et al. Blood-based biomarkers for Alzheimer’s disease: towards clinical implementation. Lancet Neurol. 2022;21(1):66–77.
   PubMed Web of Science ®Google Scholar
• Hall S, Orrù CD, Serrano GE, et al. Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease. Acta Neuropathol Commun. 2022;10(1):90.
   PubMedGoogle Scholar
• Whitwell JL, Jack CR, Kantarci K, et al. Imaging correlates of posterior cortical atrophy. Neurobiol Aging. 2007;28(7):1051–1061.
   PubMed Web of Science ®Google Scholar
• Agosta F, Mandic-Stojmenovic G, Canu E, et al. Functional and structural brain networks in posterior cortical atrophy: a two-centre multiparametric MRI study. NeuroImage Clin. 2018;19:901–910.
   PubMedGoogle Scholar
• Keyrouz SG, Labib BT, Sethi R. MRI and EEG findings in Heidenhain variant of Creutzfeldt–Jakob disease. Neurology. 2006;67(2):333.
   PubMedGoogle Scholar
• Rosenbloom MH, Alkalay A, Agarwal N, et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 2011;76(21):1789–1796.
   PubMed Web of Science ®Google Scholar
• Lim SM, Katsifis A, Villemagne VL, et al. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med Off Publ Soc Nucl Med. 2009;50:1638–1645.
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Graff-Radford J, Singh TD, et al. 18 F-FDG PET in posterior cortical atrophy and dementia with Lewy bodies. J Nucl Med. 2017;58(4):632–638.
   PubMedGoogle Scholar
• Lehmann M, Ghosh PM, Madison C, et al. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer’s disease. Brain J Neurol. 2013;136(3):844–858.
   Google Scholar
• La Joie RL, Visani AV, Lesman-Segev OH, et al. Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET. Neurology. 2021;96(5):e650–e661.
   PubMedGoogle Scholar
• McKeith I, O’Brien J, Walker Z, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6(4):305–313.
   PubMed Web of Science ®Google Scholar
• Crutch SJ, Schott JM, Rabinovici GD, et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement J Alzheimers Assoc. 2017;13(8):870–884.
   PubMed Web of Science ®Google Scholar
• Ridha BH, Crutch S, Cutler D, et al. A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer’s Disease: DONIPAD study. Alzheimers Res Ther. 2018;10(1):44.
   PubMed Web of Science ®Google Scholar
• Budd Haeberlein S, Aisen PS, Barkhof F, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease. J Prev Alzheimers Dis. 2022;9(2):197–210.
   PubMedGoogle Scholar
• van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer’s disease. N Engl J Med. 2023;388(1):9–21.
   PubMed Web of Science ®Google Scholar
• Apostolova LG, Aisen P, Eloyan A, et al. The Longitudinal Early-onset Alzheimer’s Disease Study (LEADS): framework and methodology. Alzheimers Dement. 2021;17(12):2043–2055.
   PubMedGoogle Scholar
• Yong KXX, Rajdev K, Shakespeare TJ, et al. Facilitating text reading in posterior cortical atrophy. Neurology. 2015;85(4):339–348.
   PubMedGoogle Scholar
• McGrath ER, Beiser AS, Yang Q, et al. Blood phosphorylated tau 181 predicts early, preclinical brain amyloid deposition. Alzheimers Dement. 2021;17(S5):e055485.
   Google Scholar
• Iranzo A, Fairfoul G, Ayudhaya ACN, et al. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study. Lancet Neurol. 2021;20(3):203–212.
   PubMedGoogle Scholar
• Rudge P, Hyare H, Green A, et al. Imaging and CSF analyses effectively distinguish CJD from its mimics. J Neurol Neurosurg Psychiatry. 2018;89(5):461–466.
   PubMed Web of Science ®Google Scholar
• Anumanchipalli GK, Chartier J, Chang EF. Speech synthesis from neural decoding of spoken sentences. Nature. 2019;568(7753):493–498.
   PubMed Web of Science ®Google Scholar
• Richardson ML, Lloyd-Esenkaya T, Petrini K, et al. Reading with the tongue: individual differences affect the perception of ambiguous stimuli with the brainport. Proc 2020 CHI Conf Hum Factors Comput Syst [Internet]. New York NY: Association for Computing Machinery; 2020 [Cited 2021 Oct 27]. p. 1–10. Available from: DOI:10.1145/3313831.3376184.
   Google Scholar